MARCH1, MARCH2, MARCH3, and MARCH8 are associated with CRC (8–11), MARCH1, MARCH3, and MARCH6 are correlated with hepatocellular carcinoma (12–14), and MARCH1, MARCH5, MARCH7, and MARCH10 are associated with ovarian cancer (15–18). This evidence concerns the gene MARCHF3 and hepatocellular carcinoma.